Patents by Inventor David Fluri

David Fluri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11634260
    Abstract: Disclosed herein is a transport device comprising a first section of an outer container comprising a shell on the inside having the shape of a spherical cap with an inner diameter and an opening, wherein the opening of the spherical cap faces upwards, and an inner container having an upper section, a lower section and an inner hollow volume defined thereby, wherein at least the lower section has a spherical shape on the outside, the outer diameter of which is smaller than the inner diameter of the spherical cap of the outer container. The inner container is suitable to be arranged in the spherical cap of the outer container in a freely pivotable fashion, and is capable of accommodating a payload.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: April 25, 2023
    Assignee: INSPHERO AG
    Inventors: Jan Lichtenberg, Olivier Frey, Wolfgang Moritz, David Fluri
  • Patent number: 11555171
    Abstract: The present invention relates to a microtissue compartment device, comprising a compartment structure (1) having an upper surface (2) and a lower surface (3) essentially coplanar thereto, and at least two wells (4) suitable for accommodating one or more microtissues (5) in a liquid volume, each well having a lower section (4a) with a given diameter, coaxially oriented thereto an upper section (4b) with an extended diameter, and at least one conduit (6) fluidically connecting at least two wells to one another, and at least one space (13) arranged above a well. At least one well has, in its upper section, a relief structure (9) that prevents spreading or overflow of a liquid volume comprised in said well into space (13).
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: January 17, 2023
    Inventors: Oliver Frey, Sebastian Bürgel, David Fluri, Jens Kelm, Jin-young Kim
  • Publication number: 20210245945
    Abstract: Disclosed herein is a transport device comprising a first section of an outer container comprising a shell on the inside having the shape of a spherical cap with an inner diameter and an opening, wherein the opening of the spherical cap faces upwards, and an inner container having an upper section, a lower section and an inner hollow volume defined thereby, wherein at least the lower section has a spherical shape on the outside, the outer diameter of which is smaller than the inner diameter of the spherical cap of the outer container. The inner container is suitable to be arranged in the spherical cap of the outer container in a freely pivotable fashion, and is capable of accommodating a payload.
    Type: Application
    Filed: September 5, 2019
    Publication date: August 12, 2021
    Inventors: Jan LICHTENBERG, Olivier FREY, Wolfgang MORITZ, David FLURI
  • Publication number: 20200208088
    Abstract: The present invention relates to a microtissue compartment device, comprising a compartment structure (1) having an upper surface (2) and a lower surface (3) essentially coplanar thereto, and at least two wells (4) suitable for accommodating one or more microtissues (5) in a liquid volume, each well having a lower section (4a) with a given diameter, coaxially oriented thereto an upper section (4b) with an extended diameter, and at least one conduit (6) fluidically connecting at least two wells to one another, and at least one space (13) arranged above a well. At least one well has, in its upper section, a relief structure (9) that prevents spreading or overflow of a liquid volume comprised in said well into space (13).
    Type: Application
    Filed: July 9, 2018
    Publication date: July 2, 2020
    Inventors: Oliver Frey, Sebastian Bürgel, David Fluri, Jens Kelm, Jin-young Kim
  • Patent number: 8506950
    Abstract: The invention relates to microcapsules consisting of a polymer degradable by a polypeptide comprising a drug or other compound of interest and a genetically engineered cell expressing said polypeptide in response to a triggering compound, and to methods of directed release of the compound of interest. The preferred polymer is optionally modified cellulose sulfate/poly-diallyl-dimethyl-ammonium chloride. Such microcapsules are non-toxic, do not elicit an immunological response and have an extended half-life time in mammals. The expression system for cellulase is, for example, based on TET and doxycycline, or E.REX and erythromycin. In another example, expression of cellulase is triggered by luteinizing hormone, which can be used for artificial insemination with microcapsules carrying sperm.
    Type: Grant
    Filed: September 6, 2012
    Date of Patent: August 13, 2013
    Assignees: ETH Zurich, Swissgenetics
    Inventors: Christian Kemmer, David Fluri, Ulrich Witschi, Wilfried Weber, Martin Fussenegger
  • Patent number: 8388945
    Abstract: The invention relates to microcapsules consisting of a polymer degradable by a polypeptide comprising a drug or other compound of interest and a genetically engineered cell expressing said polypeptide in response to a triggering compound, and to methods of directed release of the compound of interest. The preferred polymer is optionally modified cellulose sulfate/poly-diallyl-dimethyl-ammonium chloride. Such microcapsules are non-toxic, do not elicit an immunological response and have an extended half-life time in mammals. The expression system for cellulase is, for example, based on TET and doxycycline, or E.REX and erythromycin. In another example, expression of cellulase is triggered by luteinizing hormone, which can be used for artificial insemination with microcapsules carrying sperm.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: March 5, 2013
    Assignees: ETH Zurich, Swissgenetics
    Inventors: Christian Kemmer, David Fluri, Ulrich Witschi, Wilfried Weber, Martin Fussenegger
  • Publication number: 20130045190
    Abstract: The invention relates to microcapsules consisting of a polymer degradable by a polypeptide comprising a drug or other compound of interest and a genetically engineered cell expressing said polypeptide in response to a triggering compound, and to methods of directed release of the compound of interest. The preferred polymer is optionally modified cellulose sulfate/poly-diallyl-dimethyl-ammonium chloride. Such microcapsules are non-toxic, do not elicit an immunological response and have an extended half-life time in mammals. The expression system for cellulase is, for example, based on TET and doxycycline, or E.REX and erythromycin. In another example, expression of cellulase is triggered by luteinizing hormone, which can be used for artificial insemination with microcapsules carrying sperm.
    Type: Application
    Filed: September 6, 2012
    Publication date: February 21, 2013
    Inventors: Christian KEMMER, David Fluri, Ulrich Witschi, Wilfried Weber, Martin Fussenegger
  • Publication number: 20110177162
    Abstract: The invention relates to microcapsules consisting of a polymer degradable by a polypeptide comprising a drug or other compound of interest and a genetically engineered cell expressing said polypeptide in response to a triggering compound, and to methods of directed release of the compound of interest. The preferred polymer is optionally modified cellulose sulfate/poly-diallyl-dimethyl-ammonium chloride. Such microcapsules are non-toxic, do not elicit an immunological response and have an extended half-life time in mammals. The expression system for cellulase is, for example, based on TET and doxycycline, or E.REX and erythromycin. In another example, expression of cellulase is triggered by luteinizing hormone, which can be used for artificial insemination with microcapsules carrying sperm.
    Type: Application
    Filed: July 10, 2009
    Publication date: July 21, 2011
    Inventors: Christian Kemmer, David Fluri, Ulrich Witschi, Wilfried Weber, Martin Fussenegger